Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide.
Regeneron Pharmaceuticals stock last closed at $780.86, down 0.29% from the previous day, and has increased 25.47% in one year. It has overperformed other stocks in the Biotechnology industry by 0.41 percentage points. Regeneron Pharmaceuticals stock is currently +45.14% from its 52-week low of $538.01, and -2.45% from its 52-week high of $800.48.
There are currently 109.33M shares of REGN outstanding. The market capitalization of REGN is $85.37B. In the last 24 hours, 1.06M REGN shares were traded.
You need an online brokerage account in order to access the NASDAQ market and buy REGN stock.
We believe that eToro is the best stock brokerage. eToro gives you:
Get $10 towards your share purchase by creating an account with eToro today.Open eToro Account
Now that you've chosen the right brokerage, you need to fill out some personal details so you can invest in REGN stock today.
Now that you've opened your account on the best free stock trading app, you need to deposit funds:
Watch the tutorial below to see the process of transferring funds into your new investment account.
After you have figured out the best place to buy Regeneron Pharmaceuticals stock, it's very important to evaluate their stock prior to buying, so you can comprehend the risk and upside.
WallStreetZen was created to help average investors do better fundamental analysis.
You can see all of the due diligence checks on REGN's stock page.
You can use many financial metrics, analyses, models, and charts to gauge REGN's fair value.
Using relative valuations metrics:
You can do additional valuation research on REGN's stock here.
Out of 20 sell side analysts who give ratings on REGN, the consensus analyst rating on Regeneron Pharmaceuticals is a Buy
Please note that analyst forecasts are not stock recommendations, nor are they investment advice.
Brian Abrahams, a top 2% analyst from RBC Capital maintains REGN with a hold rating and lowers their REGN price target from $789.00 to $787.00, on Feb 6, 2023.
Brian Skorney, a top 14% analyst from Baird maintains REGN with a hold rating and raises their REGN price target from $670.00 to $756.00, on Feb 6, 2023.
Matthew Harrison, a bottom 6% analyst from Morgan Stanley maintains REGN with a strong buy rating and raises their REGN price target from $873.00 to $883.00, on Feb 6, 2023.
David Risinger, a top 9% analyst from SVB Leerink maintains REGN with a hold rating and raises their REGN price target from $770.00 to $834.00, on Feb 6, 2023.
Tyler Van Buren, a bottom 4% analyst from Cowen & Co. upgrades REGN to a buy rating and raises their REGN price target from $775.00 to $875.00, on Jan 30, 2023.
You can dive deeper into what analysts are saying on the Regeneron Pharmaceuticals stock forecast page.
Last year, REGN earnings were $4.34B. In the last 5 year, REGN's earnings have grown by 29.16% per year. This was faster than the Biotechnology industry average of 18.5%.
Last year, REGN revenue was $12.17B. Over the past five year, REGN's revenue has increased by 15.7% per year. This was slower than the Biotechnology industry average of 75.62%.
You can research REGN's earnings and revenue performance here.
In the last year, executives and large shareholders at REGN have sold more shares than they have bought.
Marion McCourt, EVP Commercial of REGN, was the latest REGN insider to sell. They sold $827,409.00 worth of REGN shares on Feb 1, 2023.
Get more info about who owns REGN shares here.
No, Regeneron Pharmaceuticals doesn't provide an income stream by paying out dividends.
One of the reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other community members have to say.
You have two main order types:
Hit the Open Trade button and your broker will execute your order.
If you require additional assistance buying stocks on eToro, click the helpful video below:
Now that you own some REGN stock, you'll want to stay up-to-date on your new company.
Make a watchlist to get notified of the latest news about your REGN stock.
To summarize, here are the 6 steps you need to take to buy Regeneron Pharmaceuticals stock right now:
If you need a brokerage account, eToro is our favorite venue.Get Started with eToro Today
If you want to get notifications regarding your new investment in Regeneron Pharmaceuticals, click below.
How much does it cost to buy one Regeneron Pharmaceuticals share?
Is now a good time to buy Regeneron Pharmaceuticals stock?
What is the best way to buy Regeneron Pharmaceuticals stock?